Diseases & Illness |

Parkinson's Disease News

Azilect Approved for Parkinson's Therapy

RSS News Feeds
Disease from Products
Parkinson's Disease
 All RSS Feeds

At a glance:

The FDA has approved a new drug for the treatment for Parkinson's Disease. Azilect (Rasagiline) was found to slow down the progress of symptoms when either used alone for early Parkinson's, or used together with Levodopa for more advanced conditions. 
 
Azilect belongs to the family of MAO inhibitors which block dopamine breakdown.  
 
A dangerous spike in blood pressure is one side-effect to watch for in patients on Azilect (or any MAO inhibitor). These patients should avoid foods high in tyramine such as red wine and cheese. Some cold preparations are also hazardous.

Azilect, a new treatment for Parkinson's Disease

Xagena.it - 5/27/2006 8:35 AM

The FDA ( U.S. Food and Drug Administration ) has approved Azilect ( Rasagiline ) for the treatment of Parkinson's disease.
 
The drug is a monoamine oxidase type--B ( MAO-B ) inhibitor that blocks the breakdown of dopamine, a chemical that sends information to the parts of the brain that control movement and coordination.
 
Parkinson's disease is a chronic, progressive neurodegenerative condition caused by the destruction of the brain cells that produce dopamine. As the level of this chemical declines, messages from the brain telling the body how and when to move are delivered more slowly, leaving a person incapable of initiating and controlling movements in a normal way
 
· Read The Full Parkinson's Disease Article From Xagena.it -->

· Read All Parkinson's Disease News Stories -->

Comments On Parkinson's Disease News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: